Login to Your Account

$30M In Funding, Too

MerLion Buys Combinature, Athelas In Three-Way Merger

By Cormac Sheridan

Tuesday, August 22, 2006
MerLion Pharmaceuticals Pte. Ltd. gained two new antibiotics that are about to enter the clinic, plus a platform for identifying novel anti-virulence molecules through its stock-based acquisition of Combinature Biopharm AG and Athelas SA. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription